Transplantation Proceedings
Volume 33, Issue 3 , Pages 2079-2080, May 2001

New immunosuppressives and clinical studies: an embarrassment of riches or more toxicity management?

  • R.D Guttmann

      Affiliations

    • McGill University Faculty of Medicine and the Institute for Policy Research in Medicine and Emerging-Technologies (IPRIME), Montréal, Canada
    • Corresponding Author InformationAddress reprint requests to Ronald D. Guttmann, MD, FRCP, McGill University Faculty of Medicine and the Institute for Policy Research in Medicine and Emerging Technologies (IPRIME), Montréal, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0041-1345(01)01956-X

Transplantation Proceedings
Volume 33, Issue 3 , Pages 2079-2080, May 2001

Article Tools